bpc-157 human clinical trials safety fda status This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the will make BPC 157 Banned: Key Facts

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients With Rheumatoid Arthritis

"At this point, we all need to be wary about putting an injection in your body without actually knowing the product," said Pessah-Pollack

That sentence contains a lot of jargon, so let us break it down

We provide a range of options depending on your levels, symptoms, and preferences

Anytime patients tell me they have a reaction from taking B vitamins, like nausea or some kind of digestive symptom, I automatically think that they might have some microbial issue

Rigorous human pharmacokinetic data do not exist because no completed Phase 1-3 clinical trials have been published